Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹3,728
  • Day's High
  • ₹3,809
₹ 3,779.70
  • 52-w low
  • ₹2,901.20
  • 52-w high
  • ₹4,074.40
3,779.70
  • Day's open
    ₹3,739
  • Previous close
    ₹3,739.10
  • VWAP
    ₹3,782.31
  • Lower price band
    ₹3,365.20
  • Upper price band
    ₹4,113

Today's Market Action

The last traded share price of Divis Laboratories Ltd was 3,779.70 up by 1.09% on the NSE. Its last traded stock price on BSE was 3,775.20 up by 0.98%. The total volume of shares on NSE and BSE combined was 580,060 shares. Its total combined turnover was Rs 219.40 crores.

Medium and Long Term Market Action

Divis Laboratories Ltd hit a 52-week high of 4,074.40 on 04-01-2024 and a 52-week low of 2,901.20 on 11-04-2023. The stock price of Divis Laboratories Ltd is up by 6% over the last one month. It is up by 29.04% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 99329

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Divis Laboratories Ltd?

What is the Market Cap of Divis Laboratories Ltd?

What is PE Ratio of Divis Laboratories Ltd?

What is PB Ratio of Divis Laboratories Ltd?

What is the CAGR of Divis Laboratories Ltd?

How to Buy Divis Laboratories Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Above Average Sustainable RoE
    The company generates a sustainable return on equity greater than the expected cost of capital which implies that the underlying business can create and compound value over a period time due to it's ability to generate above average return on capital.
  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 90.64% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
  • High Pricing Power
    The business enjoys a relatively high pricing power and is able to withstand competitive pressure which works as a great moat for equity shareholders of the company.
  • Zero Debt
    The company has almost nil to negligible debt to equity ratio of 0.00. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.
  • Above Average Growth Rate
    The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 1.45. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 235 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.

Valuation Analysis

Margin of safety
(12/04/2024)
Stock Valuation
Green line
100
74.36%
74.36% People are bullish about Divis Laboratories Ltd
25.64%
25.64 % People are bearish about Divis Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Divis Laboratories Ltd

3,779.70 +40.60 (1.09%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %